Related Experiment Video
Updated: Aug 23, 2025

Telomere Length and Telomerase Activity; A Yin and Yang of Cell Senescence
Published on: May 22, 2013
[Association between telomere length and cognitive impairment in older adults]
Martha Ramírez-Sanabria1, Jaime Martínez-Magaña2, Humberto Nicolini-Sánchez1
1Alta Especialidad en Medicina Genómica, Instituto Nacional de Medicina Genómica, Ciudad de México, México.
Introduction:
Cognitive impairment is a transition stage between normal aging and dementia, the prevalence of last one increases with age; the damage of the functions and physical integrity, places the older adult in a greater susceptibility to get sick. Telomere length is a hallmark of aging to characterize this phenotype, as well as a biomarker that reflects the underlying state of the cell. In this work, the relative length of telomeres in older adults with cognitive impairment was correlated.
Material And Methods:
Observational-analytical study, in samples of adult patients older than 65 years with and without cognitive impairment, in whom the relative length of telomeres was measured.
Results:
Ninety samples of older adults were included in the study and in the association analysis according to multivariate logistic models, cognitive impairment showed almost five times more risk for telomere shortening in relation to the presence of the diagnosis of cognitive impairment (Odds ratio 4.88, p=0.027).
Conclusions:
When correlating the relative length of telomeres in older adults diagnosed with cognitive impairment, this association was confirmed for shorter.
Related Concept Videos
Cognitive Development During Adulthood
Language and Cognition
Replicative Cell Senescence
Telomeres and Telomerase
Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

